BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18698530)

  • 1. Prisons and HCV: a review and a report on an experience in New South Wales Australia.
    Batey RG; Jones T; McAllister C
    Int J Prison Health; 2008; 4(3):156-63. PubMed ID: 18698530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
    Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
    Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.
    Gates JA; Post JJ; Kaldor JM; Pan Y; Haber PS; Lloyd AR; Dolan KA;
    J Urban Health; 2004 Sep; 81(3):448-52. PubMed ID: 15273267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk for acute hepatitis C infection during imprisonment in Australia.
    Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson W; Kaldor J; Lloyd A; Haber P
    Eur J Epidemiol; 2010 Feb; 25(2):143-8. PubMed ID: 20084429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
    Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
    Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.
    Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T
    J Viral Hepat; 2017 Feb; 24(2):111-116. PubMed ID: 27778436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance and prevention of hepatitis C in Australian prisons.
    Dolan K
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):68-9. PubMed ID: 11833205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
    Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
    Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
    Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
    Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seropositivity of hepatitis C in prison inmates of Pakistan--a cross sectional study in prisons of Sindh.
    Gorar ZA; Zulfikar I
    J Pak Med Assoc; 2010 Jun; 60(6):476-9. PubMed ID: 20527648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced chlamydia surveillance in New South Wales (Australia) prisons, 2005-2007.
    Forrest G; Boonwaat L; Douglas J; Awofeso N
    Int J Prison Health; 2009; 5(4):233-40. PubMed ID: 25757524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing assessment and treatment of hepatitis C in the custodial setting.
    Post JJ; Arain A; Lloyd AR
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of hepatitis B and C among prison population in Croatia].
    Burek V; Horvat J; Susić E; Mikulić R
    Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prisons, hepatitis C and harm minimisation.
    Levy MH; Treloar C; McDonald RM; Booker N
    Med J Aust; 2007 Jun; 186(12):647-9. PubMed ID: 17576183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of prison health and its implications for primary care nursing in England and Wales: the research evidence.
    Condon L; Gill H; Harris F
    J Clin Nurs; 2007 Jul; 16(7):1201-9. PubMed ID: 17584337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis C.
    Marinos G; Post J
    Aust Fam Physician; 2003 Oct; 32(10):804-6. PubMed ID: 14596075
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis C in prison settings: screening and therapy are improving. Comparative survey between 2000 and 2003].
    Remy AJ;
    Presse Med; 2006 Sep; 35(9 Pt 1):1249-54. PubMed ID: 16969313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.